Open original FDA record ↗Recall record
- FDA identifier
- Z-1588-2023
- Company in FDA record
- Philips North America
- FDA classification date
- May 15, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Philips has identified a compliance issue where ProxiDiagnost N90 R.1.0, CombiDiagnost R90 R.1.0 and CombiDiagnost R90 R1.1 systems are missing a certification label required by the Food and Drug Administration (FDA).
Source facts
- Action
- Philips sent an Electronic Product Radiation Correction letter dated March 3, 2023, to affected customers. The letter stated a Philips representative will contact affected customers to schedule a time for a Field Service Engineer (FSE) to visit your site to inspect your system and apply the label if necessary. Philips will, without charge, remedy the defect or bring the product into compliance with each applicable Federal standard in accordance with a plan approved by the Secretary of Health and Human Services. Customers were asked to complete and return the attached acknowledgement form to Philips DXR promptly upon receipt and no later than 30 days from receipt via email to: PD.CNR@philips.com. If you need any further information or support concerning this issue, please contact your local Philips Customer Care Solutions center: 1-800-722-9377 (Reference FCO70600112 for ProxiDiagnost N90 R.1.0 and FCO70900060 for CombiDiagnost R90 R.1.0 and R1.1).
- Initiated
- 2023-03-03
- Root cause
- Radiation Control for Health and Safety Act
- Distribution
- US Nationwide
- Recall number
- Z-1588-2023
- Recall status
- Open, Classified
- CDRH record ID
- 200327
- FDA classified
- 2023-05-15
- Recall event number
- 92333